Sorrento gets US FDA nod for Phase 1 clinical trial of neutralising antibody in COVID-19 patients Read more
US FDA denies approval to Mallinckrodt for Terlipressin to treat Hepatorenal Syndrome Type 1 Read more
Kiadis to collaborate with Abigail Wexner Research Institute for clinical trials of COVID-19 therapy Read more
Junshi Biosciences gets US FDA Breakthrough Therapy Designation for Toripalimab to treat nasopharyngeal carcinoma Read more